Compound ID | 45
PXL150
Class: Antimicrobial peptide
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Membrane-active agent |
| Target Pathogen: | Active against staphylococcal surgical site infections |
| Propensity to select resistant mutants: | Yes |
| Description: | Synthetic compound; evaluated for topical application |
| Institute where first reported: | Pergamum AB, Karolinska Institutet Science Park, Solna, Sweden |
| Year first mentioned: | 2013 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.